Abera Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2017
Period Ending	Mar '26 Mar 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2017
Market Capitalization	125	125	69	75	62	173	Upgrade
Market Cap Growth	89.42%	81.17%	-7.22%	20.46%	-64.21%	-	Upgrade
Enterprise Value	102	102	66	73	49	159	Upgrade
Last Close Price	6.10	6.80	4.51	5.16	4.80	16.55	Upgrade
PS Ratio	10.52	10.55	4.73	29.57	34.66	146.97	Upgrade
PB Ratio	6.48	6.50	8.00	13.20	3.69	5.94	Upgrade
P/TBV Ratio	6.48	6.50	8.00	13.20	3.69	5.94	Upgrade
EV/Sales Ratio	8.54	8.60	4.52	28.83	27.67	135.29	Upgrade
Net Debt / Equity Ratio	-1.22	-1.22	-0.70	-0.59	-0.92	-0.41	Upgrade
Net Debt / EBITDA Ratio	2.26	2.26	4.77	-	-	-	Upgrade
Net Debt / FCF Ratio	6.38	6.38	4.58	0.19	0.78	1.24	Upgrade
Asset Turnover	0.56	0.56	1.27	0.18	0.07	0.07	Upgrade
Quick Ratio	2.64	2.64	1.36	1.11	5.80	5.51	Upgrade
Current Ratio	2.73	2.73	2.15	2.02	6.33	5.60	Upgrade
Return on Equity (ROE)	-74.82%	-74.82%	-15.37%	-149.06%	-84.39%	-61.97%	Upgrade
Return on Assets (ROA)	-31.36%	-31.36%	-7.29%	-73.14%	-47.73%	-33.40%	Upgrade
Return on Capital Employed (ROCE)	-54.80%	-54.80%	-15.50%	-299.20%	-115.90%	-31.50%	Upgrade
Earnings Yield	-8.36%	-8.33%	-1.59%	-22.40%	-31.28%	-5.29%	Upgrade
FCF Yield	-2.95%	-2.94%	-1.92%	-23.73%	-31.78%	-5.59%	Upgrade
Buyback Yield / Dilution	-5.59%	-5.59%	-18.42%	-13.66%	-14.64%	-45.39%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.